Persistence Market Research in its recently published report titled “North America Wound Debridement Product Market 2016-2024,” offers insights into developments in the wound debridement product market in North America that are significantly transforming businesses and enterprises. While researching this report the overall market performance has been taken into consideration where the global wound debridement product market focuses on developing different products to retain market share. The report comes to a conclusion that manufacturers are focused on developing single patient use devices or medical debridement pads hoping to increase their respective market shares, while companies are focused on outsourcing the manufacturing of wound debridement pads in order to reduce their manufacturing costs and thus competing in the market with reduced prices.
This comprehensive report which focuses on the North America wound debridement product market has included a market overview including market forecast, drivers, restraints, trends and opportunities. The country-wise analysis scenario which includes price projections in U.S and Canada has also been exclusively covered while researching this report. The report further studies the value chain of the North America wound debridement product market.
The subsequent sections analyze the North America wound debridement product market on the basis of product type, application, end user and country, and present a comprehensive forecast for the period 2016–2024. The North America wound debridement product market is segmented as follows:
By Product Type
By End User
A systematic research approach has been adopted while researching this report. Rather than relying only on primary research, Persistence Market Research has done in-depth secondary research to ascertain overall market size, top industry players, top products and industry associations. Data is validated by the triangulation method, wherein secondary and primary research and Persistence Market Research analysis has contributed to the final data. Gathered data is then scrutinized to obtain qualitative and quantitative insights about the industry. The nature of the global economy being very volatile, besides estimating the Compound Annual Growth Rate (CAGR), Persistence Market Research has also analyzed the North America wound debridement product market on the basis of growth parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities likely to emerge in the North America wound debridement product market. The report also studies the different market segments by conducting a Basis Point Share (BPS) analysis to understand the relative contribution of individual segments to overall market growth.
Chronic ulcers segment is projected to account for a value share close to 45% during the forecast period
Chronic ulcers segment dominated the North America wound debridement product market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period. The chronic ulcers segment is anticipated to record an attractiveness index of 1.4 during the forecast period. This segment accounted for more than 40% value share in 2015 and is projected to account for a market value share close to 45% by the end of 2024. Research experts at Persistence Market Research predict that by the end of 2024, the chronic ulcers segment is projected to reach more than US$ 130 Mn in value, expanding at a CAGR of 8.2% over the assessment period. The detailed market research also reveals that the chronic ulcers segment revenue share in the North America wound debridement product market is expected to grow 1.9x by 2024 end as compared to that in 2016 and the segment is also expected to create absolute dollar opportunity close to US$ 5 Mn in 2017 over 2016.
Growth in chronic wounds likely to fuel demand for wound debridement products in North America
Among chronic wounds, venous insufficiency ulcers constituted 50% of chronic leg ulcers resulting in venous etiology. Annual prevalence of venous insufficiency ulcers in those aged 65 and older has been estimated to be 1.69 per 100 people per year. Prevalence of pressure ulcers varies between 0.31% and 0.70% per year in the U.S., which is in tandem with the rate of the ageing population. As per statistics from the International Diabetes Federation, it is estimated that there will be over 400 Mn diabetics worldwide by 2025, with the greatest increases being noted in Asia, Africa and Latin America. In addition, around 25% of these patients are expected to develop foot ulcers during their lifetime. Increasing diabetic patients and thereby increasing incidences of diabetic foot ulcers is fueling demand in the wound debridement product market in North America. Per capita healthcare expenditure on chronic ulcers is currently following an uptrend across both developed and developing economies, which is expected to drive the growth of the wound debridement product market in North America region.
Another factor creating robust development in the wound debridement product market is rising government support in North America. Manufacturers of wound debridement products are getting support in the form of higher reimbursement from governments in developed countries, as the prevalence of chronic wounds like ulcer is high in the U.S. Increasing awareness among the population for advanced wound care management and improved usage of wound debridement products in home care settings is expected to boost the growth of this market.
Lohmann & Rauscher GmbH & Co. has acquired Dutch manufacturer Varitex N.V.
Lohmann & Rauscher GmbH & Co., a German Company that deals with chronic wounds such as chronic ulcers has enhanced its position in the Swiss healthcare market by merging with FLAWA AG. The company also acquired Dutch compression stocking manufacturer Varitex N.V. The company is primarily focused on delivering a range of cost effective and high quality products that enhance patient safety, reduce errors and hospital acquired infections and also improve inventory management efficiency. U.K. based Smith and Nephew PLC also operates in chronic wound management devices, while U.S. based Derma Sciences Inc. offers a wide range of dressings, branded and private-label adhesive bandages, compression bandages etc. to heal chronic ulcers.